U.S., Sept. 13 -- ClinicalTrials.gov registry received information related to the study (NCT07171710) titled 'Efficacy of 0.05% Cyclosporine A Eye Drops Combined With Absorbable Tear Duct Plugs in the Treatment of Dry Eye in Sjogren's Syndrom' on Sept. 08.
Brief Summary: To study the effectiveness of 0.05% cyclosporine A eye drops in combination with smart plug absorbable lacrimal duct plugs in the monotherapy of cyclosporine for SSDE.
Study Start Date: March 01, 2024
Study Type: INTERVENTIONAL
Condition:
Dry Eye Disease
Intervention:
DRUG: 0.05% Cyclosporine Eye Drops
Cyclosporin A 0.05% eye drops were administered twice daily to both eyes
DEVICE: Smart plug absorbable lacrimal duct plugs
The lacrimal duct embolization implant is...